Home › SEC Filings › Press Releases
Press Releases
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| TEVA | PRESS-RELEASE | bullish | 5/10 | Teva announced a peer-reviewed publication in the Journal of Child Neurology summarizing the neurobiological rationale a | Oct 2, 2026 |
| TEVA | PRESS-RELEASE | bullish | 6/10 | Teva presented new Phase 2b/3 and open-label extension data for ecopipam (D1 antagonist) in pediatric Tourette syndrome | Oct 2, 2026 |
| SRZN | PRESS-RELEASE | bullish | 6/10 | Surrozen received FDA clearance to begin clinical trials of SZN-8141 for diabetic macular edema, a key pipeline mileston | Oct 2, 2026 |
| DUKR | PRESS-RELEASE | neutral | 3/10 | Duke Robotics Corp announced the strengthening of its executive leadership team to accelerate growth plans as it seeks t | Oct 2, 2026 |
| TBCVU | PRESS-RELEASE | neutral | 2/10 | Thunder Bridge Capital Partners V, Ltd. announced that its units will begin separate trading of Class A ordinary shares | Oct 2, 2026 |
| CTSH | PRESS-RELEASE | neutral | 1/10 | Cognizant Technology Solutions Corporation announced it will report its Q3 2026 results on October 29, 2026. | Oct 2, 2026 |
| IFRX | PRESS-RELEASE | neutral | 3/10 | InflaRx announced that its oral C5aR1 antagonist izicopan was selected for a late-breaking poster at ASN Kidney Week 202 | Oct 2, 2026 |
| AUGO | PRESS-RELEASE | bullish | 6/10 | Aura Minerals has signed a definitive agreement to acquire the mining fleet, equipment leases, and workforce currently o | Oct 2, 2026 |
| ALTG | PRESS-RELEASE | neutral | 2/10 | Alta Equipment Group declared its regular quarterly dividend on Series A Preferred Stock at $625 per preferred share ($0 | Oct 2, 2026 |
| CECO | PRESS-RELEASE | neutral | 3/10 | CECO Environmental announced the voluntary transfer of its primary stock listing from Nasdaq to the Texas Stock Exchange | Oct 2, 2026 |
| PYXS | PRESS-RELEASE | bearish | 7/10 | Pyxis Oncology closed a ~$110M public offering on October 1, 2026, selling 36M shares and pre-funded warrants for 1.9M s | Oct 2, 2026 |
| ARCC | PRESS-RELEASE | neutral | 1/10 | Ares Capital Corporation announced it will report its Q3 2026 results on October 27, 2026. | Oct 2, 2026 |
| TMQ | PRESS-RELEASE | neutral | 5/10 | Trilogy Metals reported Q3 2026 net income of $0.2M vs a net loss of $1.7M a year ago, driven by a non-cash mark-to-mark | Oct 2, 2026 |
| GPUS | PRESS-RELEASE | neutral | 4/10 | Hyperscale Data announced it is exploring strategic alternatives for its askROI AI subsidiary, including a potential sal | Oct 2, 2026 |
| ENSG | PRESS-RELEASE | neutral | 5/10 | The Ensign Group announced a major expansion into Florida with the acquisition of eight skilled nursing and senior livin | Oct 2, 2026 |
| ENSG | PRESS-RELEASE | neutral | 4/10 | The Ensign Group acquired the operations of 19 skilled nursing and senior living facilities across Washington, Florida, | Oct 2, 2026 |
| ENSG | PRESS-RELEASE | bullish | 6/10 | The Ensign Group acquired the operations of 7 skilled nursing facilities in Colorado, 8 facilities in Florida (713 skill | Oct 2, 2026 |
| CGEM | PRESS-RELEASE | bullish | 7/10 | Cullinan Therapeutics announced initiation of an NDA submission to the FDA for zipalertinib plus chemotherapy in first-l | Oct 1, 2026 |
| FMX | PRESS-RELEASE | neutral | 1/10 | Fomento Economico Mexicano announced it will host a conference call on October 28 to discuss its Q3 results. | Oct 1, 2026 |
| PECO | PRESS-RELEASE | neutral | 4/10 | Phillips Edison & Company reaffirmed its full-year 2026 Nareit FFO and Core FFO per share guidance (midpoint ~$2.70 and | Oct 1, 2026 |
| JAKK | PRESS-RELEASE | neutral | 1/10 | JAKKS Pacific Inc. announced it will host a conference call on October 22, 2026 to discuss its Q3 2026 results. | Oct 1, 2026 |
| BFST | PRESS-RELEASE | neutral | 1/10 | b1BANK announced it will report its Q3 2026 results on October 26. | Oct 1, 2026 |
| PECO | PRESS-RELEASE | bullish | 5/10 | Phillips Edison & Company (PECO) announced an amended joint venture with Northwestern Mutual, extending the term to 2036 | Oct 1, 2026 |
| CHRN | PRESS-RELEASE | bullish | 6/10 | ChronoScale announced a contract extension with an existing AI infrastructure customer and a new customer agreement, pro | Oct 1, 2026 |
| MHK | PRESS-RELEASE | neutral | 1/10 | Mohawk Industries, Inc. announced it will host a conference call on October 29, 2026 to discuss its Q3 results. | Oct 1, 2026 |
| ASTL | PRESS-RELEASE | bearish | 6/10 | Algoma Steel issued Q3 2026 guidance well below consensus, expecting Adjusted EBITDA of negative $10M to negative $20M a | Oct 1, 2026 |
| CSR | PRESS-RELEASE | neutral | 1/10 | Centerspace announced it will report its Q3 2026 results on November 2, 2026. | Oct 1, 2026 |
| RTX | PRESS-RELEASE | bullish | 6/10 | Raytheon, an RTX business, secured a five-year contract (with two option years) valued up to $24.4 billion for SM-6 inte | Oct 1, 2026 |
| AXGN | PRESS-RELEASE | bullish | 6/10 | Axogen completed its acquisition of BioCircuit Technologies, developer of the NerveTape sutureless nerve repair device. | Oct 1, 2026 |
| ZNTL | PRESS-RELEASE | neutral | 2/10 | Zentalis Pharmaceuticals granted inducement stock options for 62,000 shares to three newly hired employees under the 202 | Oct 1, 2026 |